Market Outlook

By 2035, the U.S. AI-Assisted Surgical Robotics Market is expected to reach approximately USD 42.06 billion, expanding at a CAGR of 16.80% during 2026–2035. The market is estimated at USD 8.90 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

The market expanded from approximately USD 4.56 billion in 2021 to USD 5.20 billion in 2022, USD 6.09 billion in 2023, and USD 7.32 billion in 2024, before reaching USD 8.90 billion in 2025. Based on the forecast trajectory, market value is expected to advance to approximately USD 10.40 billion in 2026, creating a significantly larger recurring revenue pool across robotic instruments, system utilization, AI software, service agreements, procedure analytics, and advanced surgical platforms.

For this report, AI-assisted surgical robotics includes surgeon-controlled robotic systems in which artificial intelligence, machine learning, computer vision, data analytics, intelligent planning, navigation algorithms, haptic boundaries, adaptive control, predictive workflow tools, or varying levels of task automation materially support surgery. The market includes robotic hardware, procedure-linked instruments and accessories, AI and digital software, system leases, maintenance, and associated services. Conventional laparoscopic devices without robotic intelligence and standalone AI imaging products without direct integration into surgical robotic workflows are excluded.

The commercial foundation is already substantial. Large U.S. hospitals have moved robotic surgery from a differentiating technology used primarily in prostatectomy and complex tertiary procedures toward an enterprise surgical platform spanning general surgery, gynecology, urology, thoracic surgery, orthopedics, spine, microsurgery, and selected ambulatory procedures. Intuitive Surgical alone had more than 6,300 da Vinci systems installed in the United States by the end of 2025, while competitive entry is accelerating across soft-tissue robotics, orthopedic robots, handheld systems, microsurgery platforms, spine navigation, and specialty robotic technologies.

Growth through 2035 will therefore come from more than replacement of installed robots. The larger opportunity is increasing utilization per installed system, extending robotics into high-volume routine procedures, introducing lower-footprint platforms for outpatient care, monetizing procedure data, adding intelligent planning and computer vision, and progressively moving selected surgical tasks from passive guidance toward supervised automation.

Hospital procurement is also changing. Capital committees increasingly assess surgical robotics through service-line economics rather than technological novelty. Relevant metrics include operating-room utilization, contribution margin per procedure, surgeon recruitment, minimally invasive conversion, instrument cost, turnover time, inpatient length of stay, clinical outcomes, training requirements, capital depreciation, maintenance expense, and the number of specialties that can utilize a platform. The result is a market in which AI-assisted robotic systems that improve both clinical precision and operating economics can command a larger share of hospital technology budgets.

 

Introduction

According to the U.S. AI-Assisted Surgical Robotics Market Report, the United States represents the deepest commercial environment for surgical robotics because it combines a large hospital base, sophisticated reimbursement infrastructure, high procedural volumes, strong physician adoption, academic surgical research, favorable capital availability, and intense competition among global medtech companies.

The U.S. healthcare delivery system includes approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and over 35.6 million annual hospital admissions. More than 3,500 community hospitals operate within health systems, an important factor because system ownership allows robotic platforms, purchasing contracts, training protocols, instruments, and digital infrastructure to be standardized across multiple facilities. Enterprise-level procurement can therefore convert one successful robotic implementation into a multi-hospital capital cycle.

Demographics strengthen this demand profile. The U.S. population aged 65 years and older reached approximately 61.2 million in 2024, representing about 18% of the population. Older adults account disproportionately for joint replacement, cancer surgery, urologic intervention, colorectal procedures, hysterectomy, thoracic surgery, and several other categories in which robotic assistance is expanding. The combination of aging, obesity, musculoskeletal disease, cancer prevalence, and demand for less invasive procedures creates a durable procedural base through 2035.

The market is also becoming substantially more competitive. Intuitive Surgical remains the defining incumbent in multi-specialty soft-tissue robotics, but the competitive structure is changing as Medtronic enters the U.S. with Hugo, Johnson & Johnson advances OTTAVA, CMR Surgical moves Versius Plus into the U.S., and specialist companies pursue differentiated models based on portability, open consoles, handheld robotics, microsurgical precision, outpatient economics, imaging integration, or implant-agnostic architecture.

Orthopedic robotics has developed into a second major commercial pillar. Stryker’s Mako ecosystem has passed several million procedures globally, while Zimmer Biomet, Smith+Nephew, THINK Surgical, Globus Medical, Brainlab, eCential Robotics, and other companies are using robotics, intelligent planning, real-time navigation, and data analytics to compete for knee, hip, spine, and other musculoskeletal procedures.

The AI component of the market is becoming more strategically important because current-generation surgical robots generate large amounts of structured procedural information. Instrument movement, camera position, force, kinematics, imaging, anatomy, workflow sequence, implant alignment, procedure duration, and outcome data can increasingly be analyzed to improve planning and execution. This creates a transition from robotic hardware toward software-defined surgery.

AI does not mean that the robot independently operates on the patient. In mainstream U.S. clinical practice, robotic surgery remains surgeon controlled, with AI generally functioning as an assistive intelligence layer. Over the forecast period, however, supervised autonomy is likely to expand in tightly defined tasks such as bone preparation, trajectory execution, anatomical segmentation, camera positioning, suturing assistance, or procedural step recognition.

For buyers, the strategic question is therefore moving from “Should we purchase a surgical robot?” to “Which robotic ecosystem can create the highest utilization, clinical value, data value, and economic return across our surgical network?”

 

Key Market Drivers: What’s Fueling the U.S. AI-Assisted Surgical Robotics Market Boom?

The first major driver is the expansion of robotic-assisted minimally invasive surgery into routine high-volume procedures. Robotic surgery was historically concentrated in prostatectomy and selected complex procedures, but adoption has broadened materially into hernia repair, cholecystectomy, colorectal surgery, hysterectomy, nephrectomy, thoracic procedures, and other general surgery applications. U.S. da Vinci procedure volume grew by approximately 15% in 2025, with general surgery remaining one of the most important sources of incremental cases. This matters commercially because high-frequency procedures create recurring instrument and accessory revenue rather than one-time capital revenue alone.

A second driver is the installed-base economics of U.S. hospitals. Thousands of robotic systems are already embedded in operating rooms, meaning future adoption does not start from zero. Hospitals with trained surgeons, credentialing frameworks, sterile-processing protocols, robotic coordinators, and dedicated OR teams can add indications and procedure volumes faster than facilities building a program from scratch. Increasing utilization of an existing robot can produce attractive incremental economics because the original capital infrastructure has already been deployed.

A third driver is the rise of AI-supported personalization. Orthopedic and spine platforms increasingly use CT data, intraoperative imaging, anatomical mapping, kinematic alignment, digital planning, navigation, and intelligent algorithms to tailor procedures to the individual patient. Zimmer Biomet’s newer ROSA software, for example, incorporates personalized planning and automated alignment capabilities, while competing platforms integrate haptic control, smart mapping, or real-time guidance. The value proposition is moving beyond mechanical accuracy toward reproducible personalized execution.

A fourth driver is outpatient migration. Ambulatory surgery centers and hospital outpatient departments are strategically important to the next robotics cycle because procedures continue shifting out of traditional inpatient operating rooms when safety, reimbursement, and patient selection allow. Compact robots, smaller footprints, rapid setup, lower acquisition costs, usage-based financing, and mobile platforms can broaden adoption among facilities that cannot justify traditional large-console economics.

A fifth driver is competitive entry. Intuitive’s scale has historically produced a concentrated soft-tissue robotics environment, but new U.S. clearances are widening platform choice. Medtronic received U.S. clearance for Hugo in urologic procedures in late 2025. CMR Surgical received clearance for Versius Plus for cholecystectomy. Distalmotion has authorization for Dexter in inguinal hernia repair, and MMI entered the U.S. reconstructive microsurgery market with Symani. Greater platform choice should stimulate hospital evaluation cycles, contracting innovation, physician training, and pricing competition.

A sixth driver is the demographic and surgical disease burden. More than 61 million Americans are already 65 or older. This group will generate growing demand for joint replacement, cancer surgery, pelvic surgery, urologic procedures, spine intervention, and reconstruction. Robotics becomes economically attractive where it can help surgeons perform difficult procedures minimally invasively or improve reproducibility across larger patient volumes.

A seventh driver is data monetization. The highest-value surgical robot of the future will not be defined solely by its arms or instruments. Platforms capable of capturing surgical video, procedural steps, instrument motion, imaging, outcomes, and utilization data can build decision-support tools, surgeon benchmarking, automated documentation, simulation, training, and predictive maintenance. Recurring software economics could therefore become an increasingly important component of manufacturer valuation.

An eighth driver is workforce efficiency. U.S. hospitals continue to operate under nursing, technician, specialist, and perioperative staffing pressure. A surgical robotic platform does not automatically reduce staffing, but systems that simplify docking, automate setup, reduce tray burden, improve instrument recognition, streamline turnover, or support more standardized workflows can create measurable labor advantages. This is especially important as capital committees demand productivity improvements rather than technology for its own sake.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in U.S. surgical robotics is moving from mechanical telemanipulation toward intelligent, connected, and increasingly adaptive surgery. Robotic precision remains fundamental, but the highest-growth differentiation is now being created in software, sensing, vision, procedural analytics, autonomy, and workflow design.

Computer vision is becoming one of the most important AI layers. Surgical systems can potentially identify anatomy, recognize procedural stages, follow instruments, improve camera positioning, quantify tissue or operative characteristics, and create structured data from surgical video. The long-term value is substantial because millions of procedures can generate data that improve algorithms, training, quality benchmarking, and future decision support.

Intelligent surgical planning is advancing particularly rapidly in orthopedics. Robotic knee systems increasingly create patient-specific plans using anatomy, implant parameters, alignment objectives, and intraoperative balancing information. Rather than executing a fixed generic target, the technology allows the surgeon to evaluate multiple alignment strategies before bone preparation. This turns robotics into a surgical decision platform rather than a powered positioning device.

Supervised autonomy represents the next major innovation frontier. The U.S. market is beginning to see systems capable of automating tightly controlled procedural steps under surgeon direction. Orthopedic robots are particularly well suited because bone anatomy is comparatively rigid, imaging can define boundaries, and cutting tasks can be constrained within predefined safety parameters. Zimmer Biomet’s acquisition of Monogram Technologies illustrates the strategic importance manufacturers are assigning to semi-autonomous and future fully autonomous orthopedic capabilities.

Hardware miniaturization is another competitive theme. Large capital robots can be difficult to deploy across small operating rooms and ambulatory settings. Handheld robots, modular arms, table-integrated architectures, portable platforms, and reduced-footprint systems are being developed to lower the operational barriers to robotic adoption. THINK Surgical’s TMINI and newer soft-tissue platforms illustrate this shift.

Specialty robotics is broadening the addressable market. PROCEPT BioRobotics has integrated robotic waterjet therapy with imaging and AI-supported prostate planning. MMI’s Symani applies robotic motion scaling and tremor filtration to microsurgery and supermicrosurgery. Spine platforms combine robotic guidance with three-dimensional navigation, while other companies are developing systems for ophthalmology, interventional procedures, and highly specialized anatomical environments.

Connectivity is also becoming essential. Next-generation systems are increasingly designed to connect surgical planning, intraoperative execution, video, analytics, simulation, instrument tracking, patient outcomes, and post-procedure data. This creates opportunities for hospitals to evaluate surgeons and service lines across a network rather than case by case.

Regulatory strategy is evolving with these capabilities. FDA expectations increasingly extend beyond mechanical safety toward software lifecycle management, cybersecurity, algorithm validation, human factors, data representativeness, transparency, and controls around future AI changes. Companies capable of developing robust predetermined change-control strategies may be able to update AI-enabled software more efficiently while maintaining appropriate safety and effectiveness controls.

The result is a new competitive hierarchy. Mechanical precision remains necessary, but it is increasingly insufficient. Platforms that combine robotics, AI, data, visualization, workflow intelligence, evidence generation, and favorable economics are likely to capture disproportionate value through 2035.

 

Segmentation Insights

The U.S. AI-Assisted Surgical Robotics Market is segmented on the basis of product offering, surgical specialty, AI functionality, end user, and region.

 

By Product Offering

Robotic Systems and Platforms

Robotic systems and platforms accounted for an estimated 34% of the U.S. market in 2025, representing approximately USD 3.03 billion. This category includes robotic arms, surgeon consoles, carts, imaging interfaces, navigation units, computing hardware, cameras, control systems, and integrated operating-room architecture.

The segment continues to benefit from replacement cycles, expansion into additional hospitals, increased deployment of multi-system robotic programs, and entry of competitors. Capital pricing remains important, but leasing, managed service, operating lease, per-procedure, and usage-linked arrangements are reducing the need for hospitals to make a traditional upfront purchase.

The next growth cycle will favor platforms with smaller footprints, cross-specialty capability, simplified setup, lower service requirements, and the ability to receive recurring software upgrades.

Instruments, Accessories and Procedure Consumables

Instruments, accessories, and procedure-linked consumables represented the largest product offering in 2025, with an estimated 44% market share, or approximately USD 3.92 billion.

This segment includes robotic forceps, scissors, stapling instruments, energy devices, cutters, burrs, end effectors, drapes, cannulas, disposable handpieces, procedure kits, and other limited-use instruments. Its commercial importance is substantial because revenue rises with procedure volume even when system placements slow.

Recurring instrument economics also create high switching costs. Once a health system commits to a robotic platform, instrument standardization, surgeon preference, training, inventory processes, and purchasing contracts can sustain the relationship for years.

AI Software, Digital Modules and Services

AI software, digital applications, analytics, maintenance, cloud infrastructure, procedural data services, training, and system support accounted for an estimated 22% of the market in 2025.

This is expected to be the fastest-growing product offering through 2035. Software can include preoperative planning, image segmentation, workflow recognition, smart camera functionality, kinematic algorithms, navigation, predictive analytics, surgeon performance analysis, procedure documentation, simulation, and future supervised-autonomy modules.

The economic attraction is recurring revenue. Software and services can expand lifetime customer value without requiring a new physical robot for every feature upgrade. Manufacturers capable of creating validated AI applications across an existing installed base could therefore generate disproportionately high incremental margins.

 

By Surgical Specialty

General Surgery

General surgery represented the largest surgical specialty in 2025, accounting for approximately 31% of U.S. market value. Cholecystectomy, hernia repair, colorectal surgery, bariatric surgery, appendectomy, foregut surgery, and other abdominal procedures create a broad procedural opportunity.

General surgery is strategically important because the potential case pool is much larger than the historical robotics base. U.S. robotic general surgery volumes have continued to grow strongly, making routine procedures an increasingly important contributor to system utilization.

Competition will intensify as new soft-tissue robots enter indications such as cholecystectomy and hernia repair. Hospitals will compare platforms on operating-room footprint, docking time, instrumentation, stapling and energy integration, procedure cost, surgeon training, and reliability.

Urology

Urology accounted for an estimated 21% of the market in 2025 and remains one of the most mature robotic specialties. Prostatectomy created the original commercial foundation for soft-tissue robotic surgery in the U.S., while partial nephrectomy, cystectomy, pyeloplasty, and other procedures support continued system use.

Competitive dynamics are changing following U.S. authorization of additional systems. Medtronic’s Hugo clearance for urologic procedures creates a new direct platform choice, while PROCEPT BioRobotics is expanding a specialty robotic ecosystem in prostate treatment.

Because many large hospitals already consider robotic capability standard for complex urology programs, future growth will rely more heavily on utilization, system replacement, competitive conversion, and advanced digital functionality.

Orthopedic Surgery

Orthopedic robotic surgery represented approximately 19% of 2025 market value and is expected to be one of the fastest-growing specialties.

Total knee arthroplasty remains the primary commercial application, followed by hip and partial-knee procedures. Stryker’s Mako has established a large global clinical footprint, while Zimmer Biomet ROSA, Smith+Nephew CORI, THINK Surgical TMINI, and emerging autonomous technologies are broadening competitive choice.

Orthopedics is particularly suitable for AI-assisted robotics because imaging and anatomical mapping can support patient-specific planning, alignment modeling, haptic safety boundaries, and controlled bone preparation. ASC migration is another growth catalyst because joint replacement is increasingly performed in outpatient settings.

Gynecologic Surgery

Gynecology represented an estimated 12% of the market in 2025, supported by hysterectomy, myomectomy, endometriosis procedures, sacrocolpopexy, adnexal surgery, and other minimally invasive interventions.

Robotic adoption is well established in larger U.S. hospitals. The next competitive phase is likely to focus on expanding choice beyond incumbent systems, reducing procedure cost, and improving access for lower-volume hospitals and outpatient facilities.

Gynecology also provides meaningful value for hospitals attempting to maximize multi-specialty utilization of a soft-tissue robotic platform because the same infrastructure can often support general surgery and urology.

Spine and Neurosurgery

Spine and neurosurgery accounted for approximately 10% of 2025 market value. Platforms from Globus Medical, Brainlab, eCential Robotics, Zimmer Biomet, Medtronic, and other manufacturers combine navigation, imaging, trajectory planning, robotic alignment, and real-time instrument guidance.

Spine robotics has different economics from soft-tissue robotics. Revenue is closely connected with implant ecosystems, navigation systems, imaging integration, and surgeon preference. Open or implant-agnostic robotic architectures could alter purchasing behavior by giving hospitals greater flexibility over implant contracting.

Thoracic, Cardiac, Microsurgery and Other Specialties

Thoracic surgery, selected cardiac procedures, reconstructive microsurgery, and emerging specialties represented approximately 7% of 2025 market value.

Although smaller today, these categories may deliver high growth because robotics can create capabilities that are difficult to reproduce manually. Microsurgery is a notable example: motion scaling, tremor filtration, and ultra-small articulated instruments can allow surgeons to work on anatomical structures below conventional manual limits.

Ophthalmic and other highly precise specialties may represent longer-term opportunities as regulatory evidence matures.

 

By AI Functionality

Preoperative Planning and Predictive Intelligence

Preoperative AI converts imaging, anatomy, patient characteristics, implant information, and historical procedure data into personalized surgical plans. This is most mature in orthopedics and spine but is extending into soft-tissue planning and anatomical segmentation.

The economic value is not simply better visualization. Planning tools can reduce intraoperative decision time, standardize workflows, support less-experienced users, and improve reproducibility across surgeon populations.

Computer Vision and Surgical Scene Intelligence

Computer vision is one of the most strategically valuable emerging subsegments. Algorithms can analyze endoscopic video, identify workflow steps, recognize instruments, assist anatomical segmentation, and potentially generate safety or decision-support information.

As installed robotic systems generate millions of hours of structured video, manufacturers with strong data rights, annotation capability, and clinical partnerships could build defensible AI advantages.

Real-Time Navigation and Guidance

Real-time navigation and intelligent guidance represented the largest AI-functionality category in 2025. The technology is especially mature in orthopedics, spine, and image-guided procedures, where anatomical landmarks and imaging datasets can be mapped to instrument trajectories.

Growth will be driven by increased integration between preoperative imaging and real-time intraoperative data.

Adaptive Control, Haptics and Motion Optimization

Adaptive control includes tremor filtration, motion scaling, virtual boundaries, active tracking, instrument stabilization, kinematic optimization, and haptic feedback.

These capabilities allow a robot to constrain or refine surgeon movement without replacing surgeon control. Orthopedic robots have demonstrated the commercial power of haptic boundaries, while microsurgical robots use motion scaling to translate larger hand movements into extremely precise instrument movements.

Workflow Analytics and Supervised Autonomy

Workflow analytics and supervised autonomy currently represent a smaller revenue pool but are expected to deliver the fastest expansion through 2035.

The market is moving toward automated recognition of procedure steps, smart camera control, intelligent instrument management, automated planning, controlled cutting, and other narrowly defined tasks. Full independent surgery is not expected to become the mainstream U.S. model during the forecast period. Instead, autonomy is likely to develop incrementally, with surgeons remaining responsible for planning, authorization, supervision, and intervention.

 

By End User

Hospitals and Integrated Delivery Networks

Hospitals and health systems accounted for approximately 72% of the U.S. market in 2025, representing roughly USD 6.41 billion.

They dominate because multi-specialty robots, complex cases, inpatient surgery, academic programs, and high-cost capital infrastructure remain concentrated in hospital environments. Integrated delivery networks increasingly negotiate enterprise agreements covering multiple robots, instruments, service, training, and digital software.

Hospital buyers are becoming more disciplined. New platforms must increasingly demonstrate sufficient procedure volume to cover capital and service costs, measurable clinical benefit, surgeon demand, and a pathway to increasing system utilization.

Ambulatory Surgery Centers

ASCs represented approximately 13% of 2025 market value but are positioned for above-market growth.

Robotic joint replacement, hernia repair, gynecologic surgery, and selected urologic procedures are especially relevant. The ASC market strongly favors smaller footprints, fast turnover, limited infrastructure requirements, lower capital intensity, predictable per-case economics, and flexible financing.

This creates an opening for portable and modular robotic companies that may struggle to displace an incumbent at a tertiary hospital but can design specifically around outpatient economics.

Academic and Specialty Referral Centers

Academic medical centers and high-acuity specialty hospitals accounted for approximately 11% of the market.

Their importance is significantly greater than their revenue share because they generate clinical evidence, train surgeons, participate in FDA studies, establish new procedures, and influence national adoption. Early installations of emerging robots frequently occur at these institutions because they have the clinical volume and research infrastructure required to evaluate new technology.

Physician-Owned Specialty and Other Surgical Facilities

Physician-owned surgical facilities and specialty centers represented approximately 4% of the market in 2025. Adoption remains selective because high capital costs can be difficult to justify at lower procedure volumes.

However, handheld, mobile, usage-based, and procedure-specific robotic models could significantly increase penetration through 2035.

 

Regional Insights: Where the Market is Growing Fastest?

The U.S. AI-Assisted Surgical Robotics Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand varies according to population, aging demographics, hospital density, academic medical center concentration, ASC penetration, surgeon availability, private insurance exposure, capital spending, orthopedic procedure volumes, and the presence of innovation ecosystems.

South

The South represented the largest regional market at approximately USD 3.05 billion in 2025, accounting for slightly more than one-third of U.S. market value. The region is projected to reach approximately USD 14.95 billion by 2035.

For this report, the South includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma, and the District of Columbia.

Texas is one of the most commercially important state markets in the country. Houston, Dallas-Fort Worth, San Antonio, and Austin contain large health systems, cancer programs, transplant centers, orthopedic networks, and academic medical institutions. The state’s population growth and major hospital construction pipeline support both soft-tissue and orthopedic robotic demand. Texas also offers sufficient procedure volume for health systems to operate multiple robots within individual campuses rather than relying on a single shared platform.

Florida is another major robotics market because of its large and rapidly growing older population. Joint replacement, urology, gynecology, general surgery, thoracic surgery, and cancer intervention all benefit from the state’s demographic profile. High ASC density makes Florida particularly relevant to next-generation compact robots and outpatient orthopedic systems.

North Carolina has a distinctive combination of healthcare delivery and medical technology innovation. Major academic and integrated systems, combined with the Research Triangle ecosystem, create favorable conditions for clinical trials, robotic development, data-driven surgery, and early adoption. The state also has historical strategic relevance to surgical robotics through the presence of companies and teams involved in augmented-intelligence surgery.

Georgia is developing into an important Southeastern hub. Atlanta combines major tertiary institutions, academic medicine, high procedure volumes, and regional referral traffic. Early adoption of novel procedural robotics demonstrates the state’s relevance as a launch market for emerging systems.

Tennessee benefits from Nashville’s concentration of hospital operators, surgery-center businesses, healthcare investors, and physician networks. This makes the state strategically valuable not only for procedure volume but also for procurement influence. Technology adopted by large Tennessee-based hospital and ASC operators can scale across facilities in several states.

Virginia and Maryland have sophisticated academic, military, federal, and integrated health systems, while Washington, D.C. adds high-acuity tertiary care. These markets are particularly relevant for complex robotic surgery, clinical research, oncology, and advanced image-guided procedures.

South Carolina, Kentucky, Alabama, Louisiana, Arkansas, Mississippi, West Virginia, and Oklahoma generally represent smaller individual capital markets than Texas or Florida but provide significant expansion potential. Many contain a combination of concentrated urban tertiary centers and large rural catchment areas. Robotics can support referral differentiation for regional hospitals attempting to prevent complex surgical cases from migrating to larger metropolitan systems.

Delaware is a relatively small market but benefits from proximity to the Philadelphia-Baltimore-Washington healthcare corridor.

Regional growth through 2035 will increasingly depend on ambulatory penetration. The South combines rapid population growth, expanding suburbs, physician-owned outpatient networks, and health systems that are constructing lower-cost sites of care. This creates favorable economics for smaller-footprint robotic systems.

Orthopedic robotics will be especially important in Florida, Texas, Tennessee, Georgia, and the Carolinas, while soft-tissue multi-specialty robotics will remain deeply embedded across major metropolitan hospital systems.

West

The West accounted for approximately USD 2.23 billion in 2025 and is expected to be the fastest-growing region, reaching approximately USD 12.10 billion by 2035.

The West includes California, Washington, Oregon, Arizona, Nevada, Utah, Colorado, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the region’s dominant state market and one of the most influential surgical-technology markets globally. Its importance extends far beyond population size. California combines large integrated delivery networks, internationally recognized academic medical centers, cancer hospitals, technology companies, AI expertise, venture capital, medtech headquarters, semiconductor and computing capabilities, and a culture of early digital-health adoption.

The state is particularly important for the transition from mechanical robotics toward data-driven surgery. Silicon Valley and broader California technology ecosystems provide access to machine learning engineers, computer-vision talent, cloud infrastructure, and venture financing that traditional medtech clusters may not replicate at the same scale.

California hospitals are also sophisticated purchasers. New robots face high expectations regarding clinical evidence, cybersecurity, EHR connectivity, data governance, service, surgeon training, and enterprise economics. Winning reference customers in California can therefore materially improve a manufacturer’s credibility elsewhere in the country.

Arizona and Nevada are among the strongest demographic growth opportunities. Population migration and growing retirement communities increase demand for orthopedic surgery, urology, general surgery, spine care, and other procedures associated with older populations. Phoenix and Las Vegas continue to expand tertiary and outpatient surgical infrastructure.

Colorado and Utah combine growing populations with technologically sophisticated health systems. Both markets are attractive for orthopedic and spine robotics, particularly where integrated health networks can align surgery, rehabilitation, outcomes data, and digital care pathways.

Washington and Oregon have high digital-health readiness and strong integrated delivery systems. Seattle’s technology ecosystem also provides a favorable environment for clinical AI, cloud-connected surgical platforms, and enterprise analytics.

Idaho, Montana, Wyoming, and New Mexico have smaller absolute market sizes but a distinct access problem. Surgical robotics in these states will be influenced by whether manufacturers can economically serve regional hospitals without requiring the volumes expected at major urban academic centers. Compact platforms, remote service capabilities, simulation-based training, and lower-cost acquisition models could be particularly important.

Alaska and Hawaii represent geographically isolated markets in which equipment servicing, supply logistics, training, and specialist availability can materially affect adoption. Large tertiary facilities can support advanced robotic surgery, but vendor support infrastructure is more consequential than in contiguous metropolitan markets.

The West is expected to gain share because the region is particularly receptive to AI-enabled technologies, digitally integrated surgery, outpatient migration, and new business models. Orthopedic autonomy, computer vision, cloud analytics, and advanced training platforms are likely to find some of their earliest sophisticated U.S. adopters here.

Northeast

The Northeast represented approximately USD 2.05 billion in 2025 and is projected to reach approximately USD 8.92 billion by 2035.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, and Maine.

New York is the largest state market in the region. New York City alone contains a dense concentration of academic medical centers, cancer institutions, orthopedic specialty hospitals, complex referral centers, and large health systems. Robotic technology adoption is therefore characterized by high procedural complexity and strong competition for physician recruitment.

New York is especially attractive for orthopedic robotics, complex general surgery, gynecology, urology, thoracic surgery, microsurgery, and spine. Major systems can support multiple robotic platforms simultaneously, creating opportunities for emerging vendors to establish specialty positions even where incumbents remain dominant.

Massachusetts is one of the highest-value innovation markets relative to population size. Boston’s concentration of academic medicine, biotechnology, AI research, medical-device development, venture capital, and clinical trials makes it highly influential in adoption. New systems that generate strong clinical evidence in Boston can gain national visibility rapidly.

Pennsylvania combines major academic markets in Philadelphia and Pittsburgh with a large statewide hospital base. The state is relevant to soft-tissue robotics, reconstructive surgery, orthopedics, and specialty procedures. Early U.S. microsurgical robotic cases have also demonstrated Pennsylvania’s role in evaluating novel technology.

New Jersey benefits from its proximity to New York and Philadelphia and from a dense healthcare, pharmaceutical, and medtech ecosystem. Large integrated systems and affluent suburban markets support high adoption of minimally invasive surgery and outpatient orthopedics.

Connecticut and Rhode Island offer smaller but sophisticated academic and community markets. Robotic system adoption in these states is heavily influenced by regional referral competition and affiliation with larger health networks.

Maine, Vermont, and New Hampshire have smaller populations and more dispersed care delivery. Advanced robotics remains concentrated in larger referral centers, but the aging population creates sustained need for joint replacement, cancer surgery, and other relevant specialties. Lower-footprint systems could expand access beyond tertiary centers if manufacturers can make the economics work at lower annual procedure volumes.

The Northeast is unlikely to grow as rapidly as the West because population growth is slower and robotic penetration is already relatively mature. Nevertheless, it should remain one of the most valuable markets on a per-procedure basis due to complex case mix, high specialist density, sophisticated institutions, and willingness to adopt premium technology supported by evidence.

Midwest

The Midwest represented approximately USD 1.57 billion in 2025 and is projected to reach approximately USD 6.09 billion by 2035.

The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Iowa, Missouri, Kansas, Nebraska, North Dakota, South Dakota, and Minnesota’s broader Upper Midwest referral network.

Illinois is the largest individual market in the region, with Chicago providing a dense academic, community hospital, cancer, orthopedic, and ambulatory surgical ecosystem. The city’s scale supports competitive robotic installations across multiple manufacturers and surgical specialties.

Ohio is strategically important because of its major integrated health systems and internationally recognized specialty institutions. Cleveland, Columbus, and Cincinnati provide substantial procedure volume across general surgery, urology, orthopedics, cardiac care, and complex specialty surgery.

Michigan has a large hospital base and significant joint replacement, spine, cancer, and general surgical demand. Detroit and Ann Arbor provide high-acuity medical centers capable of evaluating next-generation robotics and digital surgery platforms.

Minnesota has exceptional strategic importance because of its long-standing medical-device industry and sophisticated provider ecosystem. The Minneapolis-St. Paul region combines clinical expertise, medtech engineering, manufacturer presence, and access to experienced device executives. This creates an unusually favorable environment for robotics partnerships and development.

Indiana and Wisconsin provide stable hospital and orthopedic procedure demand, while Missouri benefits from major referral institutions in St. Louis and Kansas City.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller absolute markets and more geographically distributed patient populations. Adoption tends to be concentrated in major referral hospitals. The ability of robotic manufacturers to support these markets through efficient service, training, remote diagnostics, and compact systems will influence penetration.

The Midwest should remain particularly important for orthopedic and spine robotics because of established musculoskeletal programs, aging populations, and strong implant-company relationships. Cost discipline is typically high, however, making health-economic evidence critical. Systems that improve throughput, reduce instrument complexity, support implant flexibility, or lower capital burden may gain an advantage over premium platforms without demonstrable operating benefits.

Overall, the Midwest is expected to grow more slowly than the West and South but provide durable recurring revenue and a large replacement market. Its value lies in established surgical programs, strong health systems, orthopedic expertise, and long-term purchasing relationships.

 

Key Market Players

The U.S. AI-Assisted Surgical Robotics competitive landscape is shifting from a historically concentrated market toward a multi-platform ecosystem.

Intuitive Surgical remains the commercial leader because of its enormous U.S. installed base, recurring instrument economics, broad soft-tissue procedure adoption, surgeon training network, da Vinci 5 rollout, and expanding digital capabilities.

Medtronic has become substantially more important following U.S. clearance of the Hugo robotic-assisted surgery platform for urologic procedures. Its broader portfolio in surgical instruments, energy, stapling, navigation, and operating-room technology gives the company significant cross-selling potential.

Johnson & Johnson MedTech is a major strategic challenger through OTTAVA, Ethicon surgical instrumentation, digital surgery, DePuy Synthes, and partnerships in orthopedic and spine enabling technology. OTTAVA’s clinical and regulatory progression will be one of the most important competitive events to monitor.

Stryker holds a powerful position in orthopedic robotics through Mako SmartRobotics, supported by a large procedural evidence base, implant integration, surgeon familiarity, and extensive commercial reach.

Zimmer Biomet is expanding rapidly through ROSA Robotics, intelligent planning, analytics, handheld technology partnerships, and its acquisition of Monogram Technologies, which creates a pathway toward higher levels of autonomous orthopedic surgery.

Smith+Nephew competes with the CORI Surgical System and its Real Intelligence digital ecosystem, emphasizing portable handheld robotics, smart mapping, personalized planning, and broad knee applications.

Globus Medical is a major player in robotic spine and cranial navigation through ExcelsiusGPS and its broader musculoskeletal portfolio.

Brainlab competes through robotic alignment, navigation, intraoperative imaging, software, data integration, and digital operating-room infrastructure.

PROCEPT BioRobotics is creating a high-growth specialty robotics business in urology through AquaBeam and HYDROS, with AI-supported imaging and personalized treatment planning.

The broader core and emerging competitive ecosystem includes CMR Surgical, Distalmotion, Medical Microinstruments, Moon Surgical, THINK Surgical, Momentis Surgical, Virtual Incision, KARL STORZ/Asensus Surgical, eCential Robotics, Renishaw, Stereotaxis, Vicarious Surgical, Mendaera, ForSight Robotics, Microbot Medical, and Monogram Technologies within Zimmer Biomet.

These companies represent different strategic models. Some compete directly for multi-specialty soft-tissue procedures. Others target orthopedics, spine, microsurgery, urology, ophthalmology, endovascular procedures, or specialized minimally invasive workflows. Several are still building U.S. clinical or regulatory positions and therefore represent future competitive pressure rather than current large-scale revenue.

Market share through 2035 will depend on more than FDA authorization. Manufacturers must build surgeon training capacity, field service, instrument availability, health-economic evidence, contracting capability, cybersecurity systems, data infrastructure, procedure-specific clinical evidence, and sufficient balance-sheet capacity to support leasing and capital placements.

The industry is also likely to experience further consolidation. Large medtech companies increasingly view surgical robotics as a strategic control point because the robotic platform can influence instruments, implants, visualization, energy devices, software, procedural data, service contracts, and purchasing relationships. Acquiring an emerging robotic company can therefore protect a much larger surrounding surgical portfolio.

 

Recent Developments

The competitive environment changed materially during 2025 and into 2026.

Intuitive Surgical accelerated adoption of da Vinci 5, placing 870 systems globally during 2025 as part of a broader year in which total da Vinci placements reached 1,721. U.S. da Vinci procedure growth remained approximately 15%, reinforcing the strength of recurring procedure economics despite increasing competition.

In December 2025, Medtronic received FDA clearance for the Hugo robotic-assisted surgery system for urologic surgical procedures, formally bringing another global medtech competitor into the U.S. soft-tissue robotic surgery market. This development is strategically important because Medtronic can connect robotics with a broad portfolio of conventional minimally invasive surgical technologies.

CMR Surgical received U.S. FDA clearance for Versius Plus for cholecystectomy, establishing a pathway for U.S. commercial entry. The company is pursuing further specialty expansion, including gynecologic indications. Its modular architecture and open-console concept increase competitive differentiation in hospitals seeking alternatives to traditional robotic configurations.

Johnson & Johnson advanced OTTAVA from investigational use toward commercialization. First clinical procedures were completed in the United States in 2025, and the company subsequently submitted the system for FDA De Novo classification in early 2026. The program is strategically significant because Johnson & Johnson possesses one of the largest surgical instrument portfolios in the world and can potentially integrate robotics with Ethicon and broader digital surgery capabilities.

Orthopedic robotics underwent another important competitive shift when Zimmer Biomet completed its acquisition of Monogram Technologies in October 2025. Monogram had already received U.S. clearance for a CT-based, AI-navigated semi-autonomous knee technology and is developing a more autonomous version. The acquisition positions autonomy as a central competitive theme in future orthopedic robotics.

Zimmer Biomet also received FDA clearance for ROSA Knee with OptimiZe, adding intelligent personalized planning, automated kinematic alignment, and workflow enhancements. The technology illustrates how robotic differentiation is shifting toward algorithmic planning rather than hardware alone.

PROCEPT BioRobotics continued rapid U.S. expansion of robotic Aquablation. Its U.S. AquaBeam and HYDROS installed base had already exceeded 500 systems by the end of 2024, and subsequent FirstAssist AI developments increased the role of artificial intelligence in anatomical identification and treatment planning.

THINK Surgical’s TMINI passed 500 U.S. total knee arthroplasty procedures by early 2025 and continues expanding compatible implant options. The milestone is commercially important because it validates demand for smaller, handheld robotic systems as an alternative to large fixed platforms.

MMI’s Symani Surgical System entered the U.S. following De Novo authorization for reconstructive microsurgery. Robotic microsurgery represents a distinct growth opportunity because motion scaling and tremor filtration can extend surgeon capability at extremely small anatomical scales.

Distalmotion’s Dexter represents another important model because its authorization for inguinal hernia repair is directly aligned with outpatient migration. Flexible operating-room integration and ASC economics may become important sources of differentiation as robotics moves into less capital-intensive environments.

Regulatory evolution will remain equally important. FDA policy increasingly addresses AI software throughout its lifecycle and provides pathways for predetermined modifications to validated AI-enabled device functions. For surgical robotics manufacturers, this means future competitive advantage will depend on software-development discipline and regulatory architecture as much as mechanical engineering.

 

Conclusion

The U.S. AI-Assisted Surgical Robotics Market Size & Share is positioned to expand from approximately USD 8.90 billion in 2025 to USD 42.06 billion by 2035, representing a CAGR of 16.80% during 2026–2035.

The market is entering a second phase of commercialization. The first phase established that robotic assistance can become a standard surgical modality in high-value procedures. The second phase will determine which platforms can make robotic surgery more intelligent, more accessible, more economical, and applicable to a much larger share of U.S. procedural volume.

Soft-tissue robotics will remain the largest revenue pool, supported by general surgery, urology, gynecology, and thoracic procedures. Orthopedic robotics will be one of the strongest growth engines as intelligent planning and supervised autonomy advance. Spine navigation, urologic specialty robotics, microsurgery, and emerging procedure-specific systems will widen the addressable market further.

The South is expected to remain the largest regional market, supported by Texas, Florida, Georgia, North Carolina, Tennessee, and other high-growth states. The West should record the fastest expansion, led by California’s technology ecosystem and strong adoption of AI-enabled medicine. The Northeast will remain critical for high-acuity surgery, evidence generation, and premium technology adoption, while the Midwest will provide a durable base for orthopedic, spine, and multi-specialty robotic demand.

For hospitals and health systems, the purchasing question is becoming increasingly economic. Capital committees will favor systems that achieve high utilization across multiple specialties, shorten or standardize workflow, reduce instrument or staffing burden, attract surgeons, support minimally invasive conversion, and deliver measurable clinical and financial outcomes.

For manufacturers, competitive advantage will increasingly depend on the size and quality of the installed base, recurring procedure revenue, AI capabilities, proprietary surgical datasets, surgeon training, regulatory execution, service infrastructure, evidence generation, and the ability to integrate instruments and software into a coherent surgical ecosystem.

For investors, distributors, technology developers, and market-entry strategists, the highest-value opportunities are likely to emerge at the intersection of robotics, artificial intelligence, recurring instruments, clinical workflow data, outpatient surgery, and supervised autonomy.

By 2035, surgical robotics in the United States will be substantially less about the robot itself. Value will increasingly be created by the intelligence surrounding the robot: how effectively the platform interprets information, supports clinical judgment, executes precise tasks, learns from procedure data, integrates with the operating room, and converts technological capability into measurable patient and health-system outcomes.

 

TABLE OF CONTENT

1. U.S. AI-Assisted Surgical Robotics Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Surgical Robotics System Manufacturers
1.6.2. AI, Computer Vision and Surgical Software Developers
1.6.3. Robotic Instrument, Sensor and Component Suppliers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Academic Medical Centers and Specialty Surgical Centers
1.6.6. Ambulatory Surgery Centers
1.6.7. Group Purchasing Organizations and Surgical Technology Distributors
1.6.8. Surgeons, Clinical Decision-Makers and Robotic Program Directors
1.6.9. Payers, Regulators and Health Technology Assessment Stakeholders

What this section provides: This section defines the U.S. AI-assisted surgical robotics market boundary, research methodology, forecasting assumptions, revenue inclusions, technology scope, and stakeholder ecosystem so clients can understand precisely how the market is measured and validated.

2. U.S. AI-Assisted Surgical Robotics Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Installed Surgical Robot Base Assessment
2.8. Robotic-Assisted Procedure Volume Outlook
2.9. AI Integration and Software Monetization Outlook
2.10. High-Growth Opportunity Areas
2.11. Key Investment and Procurement Takeaways

What this section provides: This section gives decision-makers a concise view of market size, CAGR, installed-base dynamics, robotic procedure growth, AI adoption, competitive intensity, and the most attractive commercial opportunities through 2035.

3. U.S. AI-Assisted Surgical Robotics Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expansion of Robotic-Assisted Minimally Invasive Surgery
3.1.2. Increasing Robotic General Surgery Procedure Volumes
3.1.3. Growth of Robotic Orthopedic and Joint Replacement Procedures
3.1.4. Aging U.S. Population and Rising Surgical Disease Burden
3.1.5. Increasing Hospital Investment in Digital Operating Rooms
3.1.6. Growing Adoption of AI-Enabled Surgical Planning and Navigation
3.1.7. Rising Demand for Precision, Standardization and Reproducible Outcomes
3.1.8. Expansion of Surgical Robotics into Ambulatory Surgery Centers
3.1.9. Growing Competitive Entry in Soft-Tissue Surgical Robotics
3.1.10. Increasing Recurring Revenue from Instruments, Software and Services

3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Acquisition and Lifecycle Cost
3.2.2. Robotic Instrument and Procedure Cost Burden
3.2.3. Long Learning Curves and Surgeon Training Requirements
3.2.4. Limited Economic Justification at Low-Volume Surgical Facilities
3.2.5. Hospital Capital Budget Constraints
3.2.6. Cybersecurity and Connected-Device Risk
3.2.7. Clinical Evidence Requirements for AI-Enabled Functions

3.3. Opportunities and Their Impact Analysis
3.3.1. Computer Vision-Assisted Surgical Intelligence
3.3.2. Supervised and Semi-Autonomous Surgical Functions
3.3.3. AI-Based Personalized Surgical Planning
3.3.4. Compact and Mobile Surgical Robotics
3.3.5. Robotic Platforms Designed for Ambulatory Surgery Centers
3.3.6. Specialty Robotics for Microsurgery and Endoluminal Procedures
3.3.7. Robotic Spine and Neurosurgical Navigation
3.3.8. AI-Enabled Robotic Urology
3.3.9. Data Analytics and Surgical Video Intelligence
3.3.10. Usage-Based and Robotics-as-a-Service Commercial Models

3.4. Challenges and Their Impact Analysis
3.4.1. Operating Room Workflow Integration
3.4.2. Robotic System Utilization Optimization
3.4.3. Surgeon Credentialing and Training Capacity
3.4.4. Interoperability with Imaging, Navigation and Hospital IT Systems
3.4.5. AI Algorithm Validation and Dataset Representativeness
3.4.6. Technology Obsolescence and Capital Replacement Risk

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Robotic Procedure Cost-Per-Case Analysis
3.8. Hospital Capital Procurement Behavior Analysis
3.9. Robotic System Utilization and Break-Even Analysis
3.10. Surgeon Adoption and Learning Curve Analysis

What this section provides: This section explains the clinical, technological, financial and operational forces shaping U.S. surgical robotics adoption and helps clients assess market upside, implementation constraints and long-term commercialization risks.

4. U.S. AI-Assisted Surgical Robotics Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital Buyers
4.2.3. Bargaining Power of Technology and Component Suppliers
4.2.4. Substitution Risk from Conventional and Laparoscopic Surgery
4.2.5. Competitive Rivalry

4.3. Surgical Robot Capital Pricing Trend Analysis by Region, 2025–2035
4.4. Recurring Instrument and Accessory Pricing Analysis
4.5. Software Subscription and Digital Service Pricing Analysis
4.6. Value Chain & Supply Chain Analysis
4.7. Semiconductor, Sensor, Imaging and Robotic Component Supply Analysis
4.8. Impact of Digitalization and Connected Operating Rooms
4.9. AI and Computer Vision Innovation Landscape
4.10. Robotic Surgery Training and Simulation Ecosystem
4.11. FDA Regulatory Framework Analysis
4.11.1. Robotic-Assisted Surgical Device Regulation
4.11.2. AI/ML-Enabled Medical Device Regulation
4.11.3. Software Lifecycle and Predetermined Change Control Considerations
4.11.4. Cybersecurity Requirements for Connected Surgical Platforms
4.12. CMS Reimbursement and Coverage Landscape
4.13. Robotic Surgery Coding and Procedure Economics
4.14. Import/Export Restrictions & Tariff Impact
4.15. U.S. Manufacturing and Supply Localization Assessment
4.16. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.17. Hospital Value Analysis Committee Decision Framework
4.18. Technology Assessment and Capital Approval Criteria

What this section provides: This section provides a complete view of the regulatory, reimbursement, pricing, supply-chain, digital, AI, and procurement environment influencing surgical robotics adoption across U.S. healthcare organizations.

5. U.S. AI-Assisted Surgical Robotics Market – By Product Offering

5.1. Overview
5.1.1. Segment Share Analysis, By Product Offering, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)

5.2. Robotic Systems and Platforms
5.2.1. Multi-Port Surgical Robotic Systems
5.2.2. Single-Port Surgical Robotic Systems
5.2.3. Modular Robotic Systems
5.2.4. Handheld Robotic Systems
5.2.5. Specialty Procedure-Specific Robotic Systems
5.2.6. Robotic Navigation and Positioning Platforms

5.3. Instruments, Accessories and Procedure Consumables
5.3.1. Robotic Surgical Instruments
5.3.2. Robotic Stapling Instruments
5.3.3. Robotic Energy Instruments
5.3.4. End Effectors and Cutting Instruments
5.3.5. Cannulas, Trocars and Access Devices
5.3.6. Procedure Kits and Disposable Accessories
5.3.7. Robotic Orthopedic Cutting and Preparation Tools

5.4. AI Software and Digital Modules
5.4.1. Surgical Planning Software
5.4.2. Computer Vision Software
5.4.3. AI-Assisted Navigation Software
5.4.4. Surgical Video Analytics
5.4.5. Procedure Workflow Intelligence
5.4.6. Surgeon Performance Analytics
5.4.7. Automated Documentation and Data Management
5.4.8. Supervised Autonomy Software Modules

5.5. Services
5.5.1. Maintenance and Technical Support
5.5.2. Surgeon Training and Simulation
5.5.3. Software Subscription and Cloud Services
5.5.4. Data Analytics Services
5.5.5. Robotic Program Optimization Services

What this section provides: This section identifies revenue contribution and growth potential across robotic capital systems, recurring instruments, AI software, digital applications and service revenues through 2035.

6. U.S. AI-Assisted Surgical Robotics Market – By Surgical Specialty

6.1. Overview
6.1.1. Segment Share Analysis, By Surgical Specialty, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)

6.2. General Surgery
6.2.1. Hernia Repair
6.2.2. Cholecystectomy
6.2.3. Colorectal Surgery
6.2.4. Bariatric Surgery
6.2.5. Foregut Surgery
6.2.6. Other General Surgical Procedures

6.3. Urologic Surgery
6.3.1. Radical Prostatectomy
6.3.2. Partial and Radical Nephrectomy
6.3.3. Cystectomy
6.3.4. Pyeloplasty
6.3.5. Benign Prostatic Hyperplasia Procedures
6.3.6. Other Urologic Procedures

6.4. Orthopedic Surgery
6.4.1. Total Knee Arthroplasty
6.4.2. Partial Knee Arthroplasty
6.4.3. Total Hip Arthroplasty
6.4.4. Shoulder and Other Joint Procedures

6.5. Gynecologic Surgery
6.5.1. Hysterectomy
6.5.2. Myomectomy
6.5.3. Endometriosis Surgery
6.5.4. Sacrocolpopexy
6.5.5. Gynecologic Oncology Procedures
6.5.6. Other Gynecologic Procedures

6.6. Spine and Neurosurgery
6.6.1. Spinal Fusion
6.6.2. Pedicle Screw Placement
6.6.3. Cranial Procedures
6.6.4. Robotic Trajectory Guidance
6.6.5. Other Neurosurgical Applications

6.7. Thoracic Surgery
6.7.1. Lobectomy
6.7.2. Mediastinal Procedures
6.7.3. Esophageal Procedures
6.7.4. Other Thoracic Procedures

6.8. Cardiac Surgery
6.8.1. Mitral Valve Procedures
6.8.2. Coronary Revascularization Procedures
6.8.3. Other Robot-Assisted Cardiac Procedures

6.9. Microsurgery and Reconstructive Surgery
6.9.1. Lymphatic Reconstruction
6.9.2. Free-Flap Reconstruction
6.9.3. Supermicrosurgery
6.9.4. Peripheral Nerve Procedures

6.10. Other Emerging Surgical Specialties
6.10.1. Endoluminal Surgery
6.10.2. Ophthalmic Robotic Surgery
6.10.3. Interventional Robotic Procedures
6.10.4. Other Specialty Robotic Applications

What this section provides: This section evaluates robotic adoption by surgical specialty and identifies procedure areas offering the strongest combination of clinical demand, recurring instrument utilization, reimbursement opportunity and AI-enabled innovation.

7. U.S. AI-Assisted Surgical Robotics Market – By AI Functionality

7.1. Overview
7.1.1. Segment Share Analysis, By AI Functionality, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)

7.2. Preoperative Planning and Predictive Intelligence
7.2.1. Patient-Specific Surgical Planning
7.2.2. Anatomical Segmentation
7.2.3. Implant and Device Selection Support
7.2.4. Predictive Procedure Planning

7.3. Computer Vision and Surgical Scene Intelligence
7.3.1. Anatomical Recognition
7.3.2. Instrument Recognition and Tracking
7.3.3. Surgical Phase Recognition
7.3.4. Tissue Characterization
7.3.5. AI-Assisted Camera Management

7.4. Real-Time Navigation and Guidance
7.4.1. Image-Guided Robotic Navigation
7.4.2. Real-Time Anatomical Mapping
7.4.3. Trajectory Planning and Execution
7.4.4. Implant Positioning Guidance

7.5. Adaptive Control, Haptics and Motion Optimization
7.5.1. Tremor Filtration
7.5.2. Motion Scaling
7.5.3. Haptic Boundaries
7.5.4. Robotic Motion Optimization
7.5.5. Automated Instrument Stabilization

7.6. Workflow Analytics and Decision Support
7.6.1. Procedure Workflow Analytics
7.6.2. OR Efficiency Analytics
7.6.3. Surgeon Performance Analytics
7.6.4. Outcome Prediction
7.6.5. Procedure Benchmarking

7.7. Supervised and Semi-Autonomous Functions
7.7.1. Automated Bone Preparation
7.7.2. Automated Camera Control
7.7.3. Automated Trajectory Execution
7.7.4. Automated Suturing Assistance
7.7.5. Other Task-Specific Autonomous Functions

What this section provides: This section shows where artificial intelligence creates clinical and economic value within surgical robotics, from planning and visualization to navigation, motion control, analytics and emerging supervised autonomy.

8. U.S. AI-Assisted Surgical Robotics Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

8.2. Hospitals and Integrated Delivery Networks
8.2.1. Large Tertiary Hospitals
8.2.2. Community Hospitals
8.2.3. Multi-Hospital Health Systems
8.2.4. Integrated Delivery Networks

8.3. Academic Medical Centers and Teaching Hospitals
8.3.1. Clinical Research Centers
8.3.2. Robotic Surgery Training Centers
8.3.3. High-Acuity Specialty Programs

8.4. Ambulatory Surgery Centers
8.4.1. Multi-Specialty ASCs
8.4.2. Orthopedic ASCs
8.4.3. Urology ASCs
8.4.4. General Surgery ASCs

8.5. Specialty Surgical Hospitals and Centers
8.5.1. Orthopedic Specialty Hospitals
8.5.2. Cancer Surgery Centers
8.5.3. Urology Centers
8.5.4. Women’s Health Surgical Centers
8.5.5. Spine and Neurosurgical Centers

8.6. Physician-Owned and Other Surgical Facilities

What this section provides: This section identifies the U.S. care settings responsible for robotic system purchasing and procedure utilization and evaluates how adoption economics differ between large hospitals, academic centers, ASCs and specialty surgical facilities.

9. U.S. AI-Assisted Surgical Robotics Market – By Procurement & Commercial Model

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement & Commercial Model, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

9.2. Direct Capital Purchase
9.2.1. Hospital Capital Budget Procurement
9.2.2. Health System Enterprise Procurement

9.3. Operating Lease and Financing Models
9.3.1. Multi-Year Operating Lease
9.3.2. Equipment Financing
9.3.3. Managed Equipment Agreements

9.4. Usage-Based and Per-Procedure Models
9.4.1. Per-Procedure Payment
9.4.2. Minimum Procedure Commitment Models
9.4.3. Consumption-Linked Robotic Access

9.5. Robotics-as-a-Service and Subscription Models
9.5.1. Hardware Subscription
9.5.2. Software-as-a-Service
9.5.3. AI Module Subscription
9.5.4. Data and Analytics Subscription

9.6. IDN and Group Purchasing Contracts
9.6.1. Enterprise Robotic Standardization
9.6.2. Multi-Facility Contracting
9.6.3. Group Purchasing Organization Agreements

What this section provides: This section explains how U.S. healthcare organizations finance and acquire robotic surgery technology and assesses how leasing, usage-based pricing, subscription models and enterprise contracting could reshape market access.

10. U.S. AI-Assisted Surgical Robotics Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Robotic Procedure Volume Analysis
10.1.4. Regional Surgical Robot Installed Base Analysis
10.1.5. Regional Hospital and ASC Infrastructure Analysis
10.1.6. Regional AI and Digital Surgery Adoption Analysis
10.1.7. Regional Reimbursement and Procurement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Offering, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By AI Functionality, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level intelligence across all 50 U.S. states, helping clients identify robotic surgery adoption hotspots, high-volume procedural markets, hospital and ASC investment clusters, AI adoption centers, and state-level commercial opportunities.

11. U.S. AI-Assisted Surgical Robotics Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking by Robotic Platform
11.3. Installed Base Benchmarking
11.4. Robotic Procedure Volume Benchmarking
11.5. AI Capability Benchmarking
11.6. Product Portfolio and Specialty Coverage Matrix
11.7. Company Positioning Matrix
11.7.1. Leaders
11.7.2. Challengers
11.7.3. Innovators
11.7.4. Emerging Players

11.8. Company Profiles

11.8.1. Intuitive Surgical, Inc.
11.8.2. Medtronic plc
11.8.3. Johnson & Johnson MedTech
11.8.4. Stryker Corporation
11.8.5. Zimmer Biomet Holdings, Inc.
11.8.6. Smith+Nephew plc
11.8.7. Globus Medical, Inc.
11.8.8. Brainlab AG
11.8.9. PROCEPT BioRobotics Corporation
11.8.10. CMR Surgical Ltd.
11.8.11. Distalmotion SA
11.8.12. Medical Microinstruments, Inc.
11.8.13. Moon Surgical
11.8.14. THINK Surgical, Inc.
11.8.15. Momentis Surgical Ltd.
11.8.16. Virtual Incision Corporation
11.8.17. KARL STORZ / Asensus Surgical
11.8.18. eCential Robotics
11.8.19. Renishaw plc
11.8.20. Stereotaxis, Inc.
11.8.21. Vicarious Surgical Inc.
11.8.22. Mendaera, Inc.
11.8.23. ForSight Robotics Ltd.
11.8.24. Microbot Medical Inc.
11.8.25. Noah Medical Corporation

Note: Each company profile will include company overview, surgical robotics portfolio, AI capabilities, U.S. regulatory status, installed-base positioning, clinical specialty coverage, commercialization strategy, partnerships, financial positioning where available, pipeline developments, and recent strategic activity.

What this section provides: This section provides competitor benchmarking, market-share visibility, robotic platform positioning, AI capability assessment, regulatory progress and strategic intelligence on leading and emerging surgical robotics companies.

12. U.S. AI-Assisted Surgical Robotics Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact
12.2.1. Generative AI-Assisted Surgical Planning
12.2.2. Surgical Computer Vision
12.2.3. Real-Time Anatomical Intelligence
12.2.4. Semi-Autonomous Robotic Surgery
12.2.5. Autonomous Task Execution
12.2.6. AI-Enabled Orthopedic Personalization
12.2.7. Next-Generation Haptic Feedback
12.2.8. Digital Twins and Surgical Simulation
12.2.9. Surgical Video Intelligence
12.2.10. Cloud-Connected Robotic Surgery Platforms

12.3. Evolution of Robot-Assisted Surgery Toward Intelligent Surgery
12.4. Future of Multi-Port versus Single-Port Robotics
12.5. Compact and Mobile Robotic Platform Outlook
12.6. Ambulatory Surgical Robotics Outlook
12.7. Specialty Robotics Commercialization Outlook
12.8. Emerging Business and Revenue Models
12.9. Business Opportunities for Startups and Existing Players
12.10. Investment Prioritization Matrix
12.11. Technology Commercialization Readiness Matrix
12.12. White-Space Opportunity Analysis

What this section provides: This section prepares clients for changes in robotic architecture, AI capability, autonomy, outpatient deployment, commercial models and competitive structure and identifies technologies most likely to reshape the U.S. market through 2035.

13. U.S. AI-Assisted Surgical Robotics Market: Strategic Recommendations

13.1. Recommendations for Surgical Robotics Manufacturers
13.2. Recommendations for AI and Surgical Software Developers
13.3. Recommendations for Robotic Instrument and Component Suppliers
13.4. Recommendations for Hospitals and Integrated Delivery Networks
13.5. Recommendations for Academic Medical Centers
13.6. Recommendations for Ambulatory Surgery Centers
13.7. Recommendations for Investors and Private Equity Firms
13.8. Recommendations for Distributors and Channel Partners
13.9. Recommendations for New Entrants and Startups
13.10. U.S. Market Entry Strategy Considerations
13.11. Surgeon Training and Clinical Adoption Strategy
13.12. FDA Regulatory Strategy Considerations
13.13. Hospital Value Proposition Development
13.14. Pricing and Commercial Model Optimization
13.15. Product Positioning and Portfolio Expansion Guidance
13.16. AI and Data Monetization Strategy
13.17. Partnership, Licensing and M&A Opportunity Assessment

What this section provides: This section converts market intelligence into actionable recommendations for product development, U.S. market entry, clinical adoption, pricing, hospital contracting, AI monetization, investment strategy and competitive differentiation.

14. U.S. AI-Assisted Surgical Robotics Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. AI Technology Classification Limitation
14.6. Regulatory Status Limitation
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer

What this section provides: This section defines the report’s scope and methodological limitations and clarifies the legal, forecasting, regulatory, AI-classification and third-party data boundaries applicable to the U.S. AI-Assisted Surgical Robotics Market study.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. AI-Assisted Surgical Robotics Market: Market Definition and Scope
TABLE 3: U.S. AI-Assisted Surgical Robotics Market: Research Methodology Framework
TABLE 4: U.S. AI-Assisted Surgical Robotics Market: Key Assumptions
TABLE 5: U.S. AI-Assisted Surgical Robotics Market: Market Ecosystem Overview
TABLE 6: U.S. AI-Assisted Surgical Robotics Market: Stakeholder Analysis
TABLE 7: U.S. AI-Assisted Surgical Robotics Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. AI-Assisted Surgical Robotics Market: Analyst Viewpoint Summary
TABLE 9: U.S. AI-Assisted Surgical Robotics Market: Market Attractiveness Index
TABLE 10: U.S. AI-Assisted Surgical Robotics Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. AI-Assisted Surgical Robotics Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. AI-Assisted Surgical Robotics Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. AI-Assisted Surgical Robotics Market: Installed Surgical Robot Base Assessment
TABLE 14: U.S. AI-Assisted Surgical Robotics Market: Robotic-Assisted Procedure Volume Outlook
TABLE 15: U.S. AI-Assisted Surgical Robotics Market: AI Integration and Software Monetization Outlook
TABLE 16: U.S. AI-Assisted Surgical Robotics Market: Drivers; Impact Analysis
TABLE 17: U.S. AI-Assisted Surgical Robotics Market: Restraints; Impact Analysis
TABLE 18: U.S. AI-Assisted Surgical Robotics Market: Opportunities; Impact Analysis
TABLE 19: U.S. AI-Assisted Surgical Robotics Market: Challenges; Impact Analysis
TABLE 20: U.S. AI-Assisted Surgical Robotics Market: Patent & Innovation Analysis, 2021–2025
TABLE 21: U.S. AI-Assisted Surgical Robotics Market: Clinical Workflow Economics Matrix
TABLE 22: U.S. AI-Assisted Surgical Robotics Market: Robotic Procedure Cost-Per-Case Analysis
TABLE 23: U.S. AI-Assisted Surgical Robotics Market: Hospital Capital Procurement Behavior Matrix
TABLE 24: U.S. AI-Assisted Surgical Robotics Market: System Utilization and Break-Even Analysis
TABLE 25: U.S. AI-Assisted Surgical Robotics Market: PESTEL Analysis
TABLE 26: U.S. AI-Assisted Surgical Robotics Market: Porter’s Five Forces Analysis
TABLE 27: U.S. AI-Assisted Surgical Robotics Market: Surgical Robot Capital Pricing Trends, 2025–2035
TABLE 28: U.S. AI-Assisted Surgical Robotics Market: Instruments, Accessories and Software Pricing Analysis
TABLE 29: U.S. AI-Assisted Surgical Robotics Market: Value Chain Analysis
TABLE 30: U.S. AI-Assisted Surgical Robotics Market: Supply Chain Analysis
TABLE 31: U.S. AI-Assisted Surgical Robotics Market: AI and Computer Vision Innovation Landscape
TABLE 32: U.S. AI-Assisted Surgical Robotics Market: FDA Regulatory Framework Analysis
TABLE 33: U.S. AI-Assisted Surgical Robotics Market: AI/ML Medical Device Regulatory Considerations
TABLE 34: U.S. AI-Assisted Surgical Robotics Market: CMS Reimbursement and Procedure Economics Landscape
TABLE 35: U.S. AI-Assisted Surgical Robotics Market: Import/Export Restrictions & Tariff Impact
TABLE 36: U.S. AI-Assisted Surgical Robotics Market: Geopolitical and Supply-Chain Risk Assessment
TABLE 37: U.S. AI-Assisted Surgical Robotics Market: Hospital Value Analysis Committee Decision Framework
TABLE 38: U.S. AI-Assisted Surgical Robotics Market: Product Offering Snapshot, 2025
TABLE 39: Segment Dashboard; Definition and Scope, by Product Offering
TABLE 40: U.S. AI-Assisted Surgical Robotics Market, by Product Offering, 2021–2035 (US$ Billion)
TABLE 41: U.S. AI-Assisted Surgical Robotics Market: Segment Share Analysis, by Product Offering, 2025 & 2035 (%)
TABLE 42: U.S. AI-Assisted Surgical Robotics Market: Robotic Systems and Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. AI-Assisted Surgical Robotics Market: Instruments, Accessories and Procedure Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. AI-Assisted Surgical Robotics Market: AI Software and Digital Modules Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. AI-Assisted Surgical Robotics Market: Services Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. AI-Assisted Surgical Robotics Market: Surgical Specialty Snapshot, 2025
TABLE 47: Segment Dashboard; Definition and Scope, by Surgical Specialty
TABLE 48: U.S. AI-Assisted Surgical Robotics Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 49: U.S. AI-Assisted Surgical Robotics Market: Segment Share Analysis, by Surgical Specialty, 2025 & 2035 (%)
TABLE 50: U.S. AI-Assisted Surgical Robotics Market: General Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. AI-Assisted Surgical Robotics Market: Urologic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. AI-Assisted Surgical Robotics Market: Orthopedic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. AI-Assisted Surgical Robotics Market: Gynecologic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. AI-Assisted Surgical Robotics Market: Spine and Neurosurgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. AI-Assisted Surgical Robotics Market: Thoracic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. AI-Assisted Surgical Robotics Market: Cardiac Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. AI-Assisted Surgical Robotics Market: Microsurgery and Reconstructive Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. AI-Assisted Surgical Robotics Market: Other Emerging Surgical Specialties Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. AI-Assisted Surgical Robotics Market: AI Functionality Snapshot, 2025
TABLE 60: Segment Dashboard; Definition and Scope, by AI Functionality
TABLE 61: U.S. AI-Assisted Surgical Robotics Market, by AI Functionality, 2021–2035 (US$ Billion)
TABLE 62: U.S. AI-Assisted Surgical Robotics Market: Segment Share Analysis, by AI Functionality, 2025 & 2035 (%)
TABLE 63: U.S. AI-Assisted Surgical Robotics Market: Preoperative Planning and Predictive Intelligence Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. AI-Assisted Surgical Robotics Market: Computer Vision and Surgical Scene Intelligence Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. AI-Assisted Surgical Robotics Market: Real-Time Navigation and Guidance Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. AI-Assisted Surgical Robotics Market: Adaptive Control, Haptics and Motion Optimization Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. AI-Assisted Surgical Robotics Market: Workflow Analytics and Decision Support Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. AI-Assisted Surgical Robotics Market: Supervised and Semi-Autonomous Functions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. AI-Assisted Surgical Robotics Market: End User Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by End User
TABLE 71: U.S. AI-Assisted Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 72: U.S. AI-Assisted Surgical Robotics Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 73: U.S. AI-Assisted Surgical Robotics Market: Hospitals and Integrated Delivery Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. AI-Assisted Surgical Robotics Market: Academic Medical Centers and Teaching Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. AI-Assisted Surgical Robotics Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. AI-Assisted Surgical Robotics Market: Specialty Surgical Hospitals and Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. AI-Assisted Surgical Robotics Market: Physician-Owned and Other Surgical Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. AI-Assisted Surgical Robotics Market: Procurement & Commercial Model Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Procurement & Commercial Model
TABLE 80: U.S. AI-Assisted Surgical Robotics Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 81: U.S. AI-Assisted Surgical Robotics Market: Segment Share Analysis, by Procurement & Commercial Model, 2025 & 2035 (%)
TABLE 82: U.S. AI-Assisted Surgical Robotics Market: Direct Capital Purchase Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. AI-Assisted Surgical Robotics Market: Operating Lease and Financing Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. AI-Assisted Surgical Robotics Market: Usage-Based and Per-Procedure Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. AI-Assisted Surgical Robotics Market: Robotics-as-a-Service and Subscription Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. AI-Assisted Surgical Robotics Market: IDN and Group Purchasing Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. AI-Assisted Surgical Robotics Market: Regional Snapshot, 2025
TABLE 88: Segment Dashboard; Definition and Scope, by Region
TABLE 89: U.S. AI-Assisted Surgical Robotics Market, by Region, 2021–2035 (US$ Billion)
TABLE 90: U.S. AI-Assisted Surgical Robotics Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 91: West Region U.S. AI-Assisted Surgical Robotics Market: Regional Overview and Trends
TABLE 92: West Region U.S. AI-Assisted Surgical Robotics Market: Key Manufacturers and Procurement Ecosystem
TABLE 93: West Region U.S. AI-Assisted Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. AI-Assisted Surgical Robotics Market, by Product Offering, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. AI-Assisted Surgical Robotics Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. AI-Assisted Surgical Robotics Market, by AI Functionality, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. AI-Assisted Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. AI-Assisted Surgical Robotics Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 99: California AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Washington AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Arizona AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Colorado AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Oregon AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Utah AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Nevada AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: New Mexico AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Idaho AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Montana AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Wyoming AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Alaska AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Hawaii AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Northeast Region U.S. AI-Assisted Surgical Robotics Market: Regional Overview and Trends
TABLE 113: Northeast Region U.S. AI-Assisted Surgical Robotics Market: Key Manufacturers and Procurement Ecosystem
TABLE 114: Northeast Region U.S. AI-Assisted Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. AI-Assisted Surgical Robotics Market, by Product Offering, 2021–2035 (US$ Billion)
TABLE 116: Northeast Region U.S. AI-Assisted Surgical Robotics Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. AI-Assisted Surgical Robotics Market, by AI Functionality, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region U.S. AI-Assisted Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region U.S. AI-Assisted Surgical Robotics Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 120: New York AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Massachusetts AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: New Jersey AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Pennsylvania AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Connecticut AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Maine AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Vermont AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: New Hampshire AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Rhode Island AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Delaware AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: South Region U.S. AI-Assisted Surgical Robotics Market: Regional Overview and Trends
TABLE 131: South Region U.S. AI-Assisted Surgical Robotics Market: Key Manufacturers and Procurement Ecosystem
TABLE 132: South Region U.S. AI-Assisted Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 133: South Region U.S. AI-Assisted Surgical Robotics Market, by Product Offering, 2021–2035 (US$ Billion)
TABLE 134: South Region U.S. AI-Assisted Surgical Robotics Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. AI-Assisted Surgical Robotics Market, by AI Functionality, 2021–2035 (US$ Billion)
TABLE 136: South Region U.S. AI-Assisted Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 137: South Region U.S. AI-Assisted Surgical Robotics Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 138: Texas AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Florida AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Georgia AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: North Carolina AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Tennessee AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: South Carolina AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Alabama AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Mississippi AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Louisiana AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Arkansas AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Kentucky AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Oklahoma AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Virginia AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Maryland AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: West Virginia AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Midwest Region U.S. AI-Assisted Surgical Robotics Market: Regional Overview and Trends
TABLE 154: Midwest Region U.S. AI-Assisted Surgical Robotics Market: Key Manufacturers and Procurement Ecosystem
TABLE 155: Midwest Region U.S. AI-Assisted Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 156: Midwest Region U.S. AI-Assisted Surgical Robotics Market, by Product Offering, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. AI-Assisted Surgical Robotics Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. AI-Assisted Surgical Robotics Market, by AI Functionality, 2021–2035 (US$ Billion)
TABLE 159: Midwest Region U.S. AI-Assisted Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region U.S. AI-Assisted Surgical Robotics Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 161: Illinois AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Ohio AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Michigan AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Minnesota AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Indiana AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Wisconsin AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Missouri AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Iowa AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Kansas AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Nebraska AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: North Dakota AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: South Dakota AI-Assisted Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: U.S. AI-Assisted Surgical Robotics Market: Competitive Landscape Snapshot, 2025
TABLE 174: U.S. AI-Assisted Surgical Robotics Market: Key Company Market Share Analysis, 2025
TABLE 175: U.S. AI-Assisted Surgical Robotics Market: Company Positioning Matrix
TABLE 176: U.S. AI-Assisted Surgical Robotics Market: Installed Base Benchmarking
TABLE 177: U.S. AI-Assisted Surgical Robotics Market: Robotic Procedure Volume Benchmarking
TABLE 178: U.S. AI-Assisted Surgical Robotics Market: AI Capability Benchmarking
TABLE 179: U.S. AI-Assisted Surgical Robotics Market: Product Portfolio and Specialty Coverage Matrix
TABLE 180: U.S. AI-Assisted Surgical Robotics Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 181: Intuitive Surgical, Inc.: Company Profile
TABLE 182: Medtronic plc: Company Profile
TABLE 183: Johnson & Johnson MedTech: Company Profile
TABLE 184: Stryker Corporation: Company Profile
TABLE 185: Zimmer Biomet Holdings, Inc.: Company Profile
TABLE 186: Smith+Nephew plc: Company Profile
TABLE 187: Globus Medical, Inc.: Company Profile
TABLE 188: Brainlab AG: Company Profile
TABLE 189: PROCEPT BioRobotics Corporation: Company Profile
TABLE 190: CMR Surgical Ltd.: Company Profile
TABLE 191: Distalmotion SA: Company Profile
TABLE 192: Medical Microinstruments, Inc.: Company Profile
TABLE 193: Moon Surgical: Company Profile
TABLE 194: THINK Surgical, Inc.: Company Profile
TABLE 195: Momentis Surgical Ltd.: Company Profile
TABLE 196: Virtual Incision Corporation: Company Profile
TABLE 197: KARL STORZ / Asensus Surgical: Company Profile
TABLE 198: eCential Robotics: Company Profile
TABLE 199: Renishaw plc: Company Profile
TABLE 200: Stereotaxis, Inc.: Company Profile
TABLE 201: Vicarious Surgical Inc.: Company Profile
TABLE 202: Mendaera, Inc.: Company Profile
TABLE 203: ForSight Robotics Ltd.: Company Profile
TABLE 204: Microbot Medical Inc.: Company Profile
TABLE 205: Noah Medical Corporation: Company Profile
TABLE 206: U.S. AI-Assisted Surgical Robotics Market: Future Market Scenario Analysis, 2026–2035
TABLE 207: U.S. AI-Assisted Surgical Robotics Market: Disruptive Technologies Impact Matrix
TABLE 208: U.S. AI-Assisted Surgical Robotics Market: AI and Autonomy Evolution Roadmap
TABLE 209: U.S. AI-Assisted Surgical Robotics Market: Ambulatory Surgical Robotics Outlook
TABLE 210: U.S. AI-Assisted Surgical Robotics Market: Specialty Robotics Commercialization Outlook
TABLE 211: U.S. AI-Assisted Surgical Robotics Market: Emerging Business Trends
TABLE 212: U.S. AI-Assisted Surgical Robotics Market: Business Opportunities for Startups and Existing Players
TABLE 213: U.S. AI-Assisted Surgical Robotics Market: Investment Prioritization Matrix
TABLE 214: U.S. AI-Assisted Surgical Robotics Market: Technology Commercialization Readiness Matrix
TABLE 215: U.S. AI-Assisted Surgical Robotics Market: White-Space Opportunity Analysis
TABLE 216: U.S. AI-Assisted Surgical Robotics Market: Strategic Recommendations for Surgical Robotics Manufacturers
TABLE 217: U.S. AI-Assisted Surgical Robotics Market: Strategic Recommendations for AI and Surgical Software Developers
TABLE 218: U.S. AI-Assisted Surgical Robotics Market: Strategic Recommendations for Hospitals and IDNs
TABLE 219: U.S. AI-Assisted Surgical Robotics Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 220: U.S. AI-Assisted Surgical Robotics Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 221: U.S. AI-Assisted Surgical Robotics Market: Strategic Recommendations for New Entrants and Startups
TABLE 222: U.S. AI-Assisted Surgical Robotics Market: U.S. Market Entry Strategy Considerations
TABLE 223: U.S. AI-Assisted Surgical Robotics Market: FDA Regulatory Strategy Considerations
TABLE 224: U.S. AI-Assisted Surgical Robotics Market: Pricing and Commercial Model Optimization
TABLE 225: U.S. AI-Assisted Surgical Robotics Market: AI and Data Monetization Strategy
TABLE 226: U.S. AI-Assisted Surgical Robotics Market: Partnership, Licensing and M&A Opportunity Assessment
TABLE 227: U.S. AI-Assisted Surgical Robotics Market: Scope Limitation
TABLE 228: U.S. AI-Assisted Surgical Robotics Market: Market Definition Limitation
TABLE 229: U.S. AI-Assisted Surgical Robotics Market: Data Use Limitation
TABLE 230: U.S. AI-Assisted Surgical Robotics Market: Forecasting Limitation
TABLE 231: U.S. AI-Assisted Surgical Robotics Market: AI Technology Classification Limitation
TABLE 232: U.S. AI-Assisted Surgical Robotics Market: Regulatory Status Limitation
TABLE 233: U.S. AI-Assisted Surgical Robotics Market: Legal Disclaimer
TABLE 234: U.S. AI-Assisted Surgical Robotics Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. AI-Assisted Surgical Robotics Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Map
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Robotic Procedure Cost-Per-Case Framework
FIGURE 13: Hospital Capital Procurement Decision Framework
FIGURE 14: U.S. AI-Assisted Surgical Robotics Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 15: U.S. AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 16: U.S. AI-Assisted Surgical Robotics Market Year-wise Growth Curve, 2021–2035
FIGURE 17: U.S. Installed Surgical Robot Base Trend
FIGURE 18: U.S. Robotic-Assisted Procedure Volume Outlook
FIGURE 19: AI Integration and Software Monetization Roadmap
FIGURE 20: Product Offering Segment Market Share Analysis, 2025 & 2035
FIGURE 21: Product Offering Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Surgical Specialty Segment Market Share Analysis, 2025 & 2035
FIGURE 23: Surgical Specialty Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: AI Functionality Segment Market Share Analysis, 2025 & 2035
FIGURE 25: AI Functionality Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 27: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Procurement & Commercial Model Segment Market Share Analysis, 2025 & 2035
FIGURE 29: Procurement & Commercial Model Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Robotic Systems and Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Instruments, Accessories and Procedure Consumables Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: AI Software and Digital Modules Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: General Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Urologic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Orthopedic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Computer Vision and Surgical Scene Intelligence Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Real-Time Navigation and Guidance Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Supervised and Semi-Autonomous Functions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Hospitals and Integrated Delivery Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Robotics-as-a-Service and Subscription Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 43: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: West Region U.S. AI-Assisted Surgical Robotics Market Share and Leading Players, 2025
FIGURE 45: West Region Market Share Analysis by State, 2025
FIGURE 46: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: California AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Washington AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Arizona AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Colorado AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Oregon AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Utah AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Nevada AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: New Mexico AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Idaho AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Montana AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Wyoming AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Alaska AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Hawaii AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Northeast Region U.S. AI-Assisted Surgical Robotics Market Share and Leading Players, 2025
FIGURE 61: Northeast Region Market Share Analysis by State, 2025
FIGURE 62: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: New York AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Massachusetts AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: New Jersey AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Pennsylvania AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Connecticut AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Maine AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Vermont AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: New Hampshire AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Rhode Island AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Delaware AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: South Region U.S. AI-Assisted Surgical Robotics Market Share and Leading Players, 2025
FIGURE 74: South Region Market Share Analysis by State, 2025
FIGURE 75: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Texas AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Florida AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Georgia AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: North Carolina AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Tennessee AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: South Carolina AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Alabama AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Mississippi AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Louisiana AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Arkansas AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Kentucky AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Oklahoma AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Virginia AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Maryland AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: West Virginia AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Midwest Region U.S. AI-Assisted Surgical Robotics Market Share and Leading Players, 2025
FIGURE 92: Midwest Region Market Share Analysis by State, 2025
FIGURE 93: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Illinois AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Ohio AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Michigan AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Minnesota AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Indiana AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Wisconsin AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Missouri AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Iowa AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Kansas AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Nebraska AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: North Dakota AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: South Dakota AI-Assisted Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 107: Company Positioning Matrix
FIGURE 108: Installed Base Benchmarking of Key Players
FIGURE 109: Robotic Procedure Volume Benchmarking
FIGURE 110: AI Capability Benchmarking of Key Players
FIGURE 111: Key Player Product Portfolio and Specialty Coverage Benchmarking
FIGURE 112: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 113: U.S. Surgical Robotics Innovation Roadmap
FIGURE 114: Computer Vision and Surgical Intelligence Roadmap
FIGURE 115: Supervised Autonomy Adoption Roadmap
FIGURE 116: Ambulatory Surgical Robotics Opportunity Map
FIGURE 117: Future Market Scenario Analysis, 2026–2035
FIGURE 118: Disruptive Technologies Impact Matrix
FIGURE 119: Emerging Business Trends Matrix
FIGURE 120: Investment Prioritization Matrix
FIGURE 121: Technology Commercialization Readiness Matrix
FIGURE 122: White-Space Opportunity Map
FIGURE 123: Strategic Growth Roadmap for U.S. AI-Assisted Surgical Robotics Companies
FIGURE 124: U.S. Market Entry Strategy Framework
FIGURE 125: Pricing and Commercial Model Optimization Framework
FIGURE 126: AI and Data Monetization Strategy Framework
FIGURE 127: Partnership, Licensing and M&A Opportunity Framework
FIGURE 128: Report Scope and Disclaimer Framework